Literature DB >> 24233861

A retrospective survey of community based utilization of Tay Sachs screening in Eight New Jersey counties.

R Wallerstein1, K Seshadri, S Brady-Yasbin, L Y Shih, D F Wallerstein.   

Abstract

The purpose of this study was to determine the rate of utilization of Tay Sachs disease screening by the Ashkenazi Jewish population. Pregnant women who were referred to one of three genetic centers in New Jersey for amniocentesis unrelated to Tay Sachs screening were the study population. 4490 charts were reviewed retrospectively to determine the at risk population for Tay Sachs disease (Ashkenazi Jews) and whether or not patients and their spouses had elected Tay Sachs screening prior to referral. A group of 25 patients who did not elect screening were questioned as to their specific reason for declining Tay Sachs screening. Overall community utilization was 90%. Of the couples who did not elect screening, 64% felt that their risk to have an affected child was too small, 16% could not recall Tay Sachs screening being offered to them, 8% felt that screening was inconvenient. Tay Sachs screening as a voluntary preventive health care program has a high utilization rate in our study group.

Entities:  

Year:  1994        PMID: 24233861     DOI: 10.1007/BF01423174

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  9 in total

1.  Perceived risk not actual risk predicts uptake of amniocentesis.

Authors:  T M Marteau; J Kidd; R Cook; S Michie; M Johnston; J Slack; R W Shaw
Journal:  Br J Obstet Gynaecol       Date:  1991-03

2.  Effects of genetic screening on perceptions of health: a pilot study.

Authors:  T M Marteau; M van Duijn; I Ellis
Journal:  J Med Genet       Date:  1992-01       Impact factor: 6.318

3.  Genetic screening for ethnic minorities.

Authors:  M Modell; B Modell
Journal:  BMJ       Date:  1990-06-30

4.  Temporal changes in the utilization of amniocentesis for prenatal diagnosis by women of advanced maternal age, 1976-1983.

Authors:  P A Baird; A D Sadovnick; B C McGillivray
Journal:  Prenat Diagn       Date:  1985 May-Jun       Impact factor: 3.050

5.  The control of genetic disease by carrier screening and antenatal diagnosis: social, ethical, and medicolegal issues.

Authors:  M M Kaback
Journal:  Birth Defects Orig Artic Ser       Date:  1982

6.  Midtrimester genetic amniocentesis in eastern Ontario: a review from 1970 to 1985.

Authors:  A G Hunter; D Thompson; M Speevak
Journal:  J Med Genet       Date:  1987-06       Impact factor: 6.318

7.  The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin.

Authors:  G M Petersen; J I Rotter; R M Cantor; L L Field; S Greenwald; J S Lim; C Roy; V Schoenfeld; J A Lowden; M M Kaback
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

8.  Uptake of amniocentesis in women aged 38 years or more by the time of the expected date of delivery: a two-year retrospective study.

Authors:  P D Knott; R J Penketh; M K Lucas
Journal:  Br J Obstet Gynaecol       Date:  1986-12

9.  Tay-Sachs' and Sandhoff's diseases: the assignment of genes for hexosaminidase A and B to individual human chromosomes.

Authors:  F Gilbert; R Kucherlapati; R P Creagan; M J Murnane; G J Darlington; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.